Viatris acquires Pacira BioSciences for $1.65 billion

Statements (8)

1. ● Neutral

   Viatris acquired Pacira BioSciences for US$1.65 billion to strengthen its pain treatment portfolio.

   valor.globo.comOct 8, 2026 18:17 UTC
2. ▲ Bullish

   Viatris is acquiring Pacira BioSciences for $1.65 billion in a cash deal.

   endpoints.newsOct 8, 2026 18:13 UTCHigh importance
3. ▲ Bullish

   Pacira BioSciences stock surged 44% following a $1.7 billion acquisition by Viatris

   barrons.comOct 8, 2026 16:01 UTCHigh importance
4. ● Neutral

   Viatris acquired Pacira for $1.7 billion to expand its pain drug portfolio

   biopharmadive.comOct 8, 2026 16:00 UTCHigh importance
5. ● Neutral

   Pacira BioSciences is being acquired by Viatrias.

   nasdaq.comOct 8, 2026 15:33 UTCHigh importance
6. ▲ Bullish

   Viatris is acquiring Pacira Biosciences for $1.65 billion in a takeover deal.

   investors.comOct 8, 2026 15:15 UTCHigh importance
7. ● Neutral

   Viatris agreed to acquire Pacira BioSciences for $1.65 billion in a deal that expands the healthcare company's medicines portfolio.

   wsj.comOct 8, 2026 12:48 UTCHigh importance
8. ▲ Bullish

   Viatris agrees to acquire Pacira BioSciences for an undisclosed amount

   prnewswire.comOct 8, 2026 11:45 UTCHigh importance